Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biotech Reports 'Eye-Catching, Topline Results' from RSV Vaccine Study

The data and how the asset stacks up to others were covered in a ROTH Capital Partners report. Syringe In a June 14 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Enanta Pharmaceuticals Inc.'s (ENTA:NASDAQ) EDP-928 ...
Streetwise Reports | June 21, 2019 |

Buzz on the Bullboards: Rapid growth, or mild swelling?

It has been another rocky week for North American markets as traders continue to weigh the risks of inflation and the health of the financial sector. Canada’s own main stock index recently hit a two-week low, but in the face of every performance in the red...
Jonathon Brown | April 27, 2023 |

Aphria, Aurora Cannabis, Canopy Growth, EXMceuticals - do not miss the entry!

The German nationwide and anonymous advertising format of Deutsche Post is called POSTAKTUELL and is published regularly in large print runs. The stack of advertising is wrapped in a foil and the practical added value for the recipient is the TV guide. The front of POSTAKTUELL...
Mario Hose | May 19, 2020 |

Will gold be Paulson's next "Greatest Trade Ever?"

When famed hedge-fund manager John Paulson speaks, people listen. And it's no wonder. Paulson made his way into the financial history books thanks to what many now call the "greatest trade ever." Paulson & Co. shorted the subprime mortgage market before the collapse ba...
Peter Krauth | October 28, 2012 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

Why Fortune Favours Chris Taylor’s Kodiak Copper

It’s a stark new reality. And investors need to listen up or lose out. Truth be told, it is no longer only the size and grade of each new mineral discovery that determines whether it can become a mine. Now, all exploration/development projects also need to ...
Marc Davis | January 24, 2022 |

Natural Gas Price Fundamental Daily Forecast – Bearish as Long as Forecast is Accurate

Weekend runs from both the American and European models advertised “a big move warmer,” shedding around 15-20 gas-weighted degree days from the 15-day outlook, according to Bespoke Weather Services. James Hyerczyk ...
FX Empire | December 11, 2019 |

Gold To Continue To Base Below $1320 For Weeks

Our research team, at Technical Traders Ltd., believes Gold will continue to base below $1320 for at least another 3~5 weeks before setting up a momentum price base. Our research suggests general weakness in the US stock market over the next few weeks/months as a Head-n-Should...
Chris Vermeulen | March 20, 2019 |

Yield Curve Inverted Again. Will Gold Shine Now?

The U.S. yield curve has inverted again, and it has done so to the widest level since 2007. How much of a reason to worry is that actually? A sky-is-falling moment lurking ahead? If so, what chance of saving us does gold have? Another Yield Curve Inversion Occurs It&Clo...
Arkadiusz Sieron | June 11, 2019 |

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 ...

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse®...
Streetwise Reports | March 23, 2020 |
1 2 3 4 5 6 7